T1 Condition 1779 1784 tumor
T2 Gene 1756 1764 cytokine
T3 Biomarker 878 891 – minocycline
T4 Biomarker 1198 1209 telmisartan
T5 Biomarker 398 399 –
T6 Biomarker 878 879 –
T7 Level 674 704 attracts circulating monocytes
T8 Level 1470 1498 malignant glioblastoma cells
T9 Biomarker 954 955 –
T10 Biomarker 1326 1338 temozolomide
T11 Gene 1625 1630 MCP-1
T12 Level 152 188 nonmalignant monocyte lineage cells 
T13 Level 196 204 monocyte
T14 Level 165 173 monocyte
T15 Condition 457 462 tumor
T17 Condition 1598 1610 glioblastoma
T18 Intervention 1546 1570 nonmalignant macrophages
T20 Level 695 704 monocytes
T21 Gene 1002 1007 MCP-1
T22 Protein 1857 1860 MTZ
T23 Biomarker 918 919 –
T24 Level 732 740 monocyte
T26 Level 1559 1569 macrophage
T27 Protein 364 368 MLCs
T28 Biomarker 1249 1250 –
T29 Gene 1700 1705 MCP-1
T30 Level 695 703 monocyte
T31 Condition 321 333 glioblastoma
T32 Gene 1880 1885 MCP-1
T33 Level 587 605 Glioblastoma cells
T34 Biomarker 920 931 telmisartan
T35 Protein 189 193 MLCs
T36 Condition 270 275 tumor
T37 Condition 345 350 tumor
T38 Level 732 741 monocytes
T39 Biomarker 1231 1232 –
T40 Condition 406 418 glioblastoma
T41 Protein 1237 1240 MTZ
T42 Condition 573 578 tumor
T43 Gene 800 805 MCP-1
T44 Level 1598 1616 glioblastoma cells
T45 Condition 1480 1492 glioblastoma
T46 Condition 111 123 glioblastoma
T47 Level 218 227 microglia
T48 Intervention 1661 1666  MLCs
T49 Condition 1836 1841 tumor
T51 Gene 656 668 13 kDa MCP-1
T52 Condition 1929 1941 glioblastoma
T54 Level 288 306 nonmalignant cells
T55 Condition 712 717 tumor
T56 Intervention 363 368  MLCs
T57 Level 1574 1583 microglia
T58 Biomarker 939 971 bisphosphonate – zoledronic acid
T59 Condition 28 40 glioblastoma
